Human DNA topoisomerase-IIα expression as a prognostic factor for transitional cell carcinoma of the urinary bladder
Article first published online: 26 MAR 2003
Volume 91, Issue 6, pages 489–492, January 2003
How to Cite
Koren, R., Kugel, V., Dekel, Y., Weissman, Y., Livne, P.M. and Gal, R. (2003), Human DNA topoisomerase-IIα expression as a prognostic factor for transitional cell carcinoma of the urinary bladder. BJU International, 91: 489–492. doi: 10.1046/j.1464-410X.2003.04118.x
- Issue published online: 26 MAR 2003
- Article first published online: 26 MAR 2003
- Accepted for publication 26 October 2002
- topoisomerase II-α;
- transitional cell carcinoma;
- urothelial tumour;
To investigate the immunohistochemical expression of topoisomerase II-α (TII-α, a nuclear enzyme, the expression of which increases rapidly at the end of the S to G2/M phase and declines when mitosis ends) in bladder urothelial neoplasms (transitional cell carcinoma), and its correlation with grade, stage and survival.
patients and methods
Histological sections from 57 urothelial neoplasms were stained immunohistochemically for TII-α expression; the percentage of positive cells in the area of greatest staining was recorded as the TII-α index.
TII-α nuclear staining was positive in all the samples except one. The mean (sd) TII-α index was 10.7 (5.9) in urothelial neoplasms of low malignant potential (grade 1), 15.5 (5.0) in low-grade (grade 2) and 42.1 (13.4) in high-grade urothelial carcinoma (grade 3). The mean TII-α index was 10.7 (5.9), 26.3 (14.8) and 44 (19) in stages pTa, pT1 and pT2, respectively. The TII-α index was significant for predicting death from cancer, independently of the stage or grade of the disease (P = 0.019, hazard ratio 1.1).
A higher TII-α index indicates a greater probability of recurrence of disease and lower overall survival. Therefore TII-α expression has prognostic value in bladder carcinoma.